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Background: Abacavir is an effective therapeutic nucleoside analogue used in the 
treatment of HIV infection that is associated with hypersensitivity reactions in ~8% of 
individuals. Susceptibility to abacavir hypersensitivity (ABC-HSR) is highly 
predicted by the presence of alleles on the 57.1 ancestral haplotype including HLA-
B*5701, TNF –238A, and Hsp70Hom-493T. 
Objective:  To examine the metabolic and immune responses in the pathogenesis of 
ABC-HSR.  
Methods: Cellular HSP70, CD40 and IFN-γ expression were measured by immuno -
fluorescence staining using confocal microscopy, intracellular flow cytometry (ICS) 
and ELISA. Alcohol dehydrogenase activity was determined by spectrophotometric 
analysis of NADH production.  
Results : Confocal microscopy revealed significantly increased HSP70 expression in 
endosomal compartments of antigen presenting cells within 3 hours of abacavir 
stimulation in cultured PBMCs from HLA-B*5701+ ABC-HSR and HLA-B*5701+ 
ABC-naive individuals, compared with ABC-tolerant patients (P=0.023). Blockade of 
cell surface receptors with CD14, HSP70 or TLR4 antibodies reduced HSP70 
redistribution in susceptible individuals to basal levels (P<0.004). CD40 expression, 
an activation and maturation marker, was significantly higher in CD14+, CD83+ cells 
from HSR versus tolerant patients (P=0.0008). Abacavir stimulation resulted in 
increased T1 cytokine expression including monocyte TNF-α (ICS, P=0.0003) and 
IFN-γ (ELISA, P=0.001) associated in ABC HSR compared with tolerant patients. 
The IFN-γ response was observed in CD8+ T cells (ICS). Inhibiting abacavir 
bioactivation via ADH with 4-MP decreased both HSP70 redistribution and IFN 
γ production.  
Conclusions: Both innate and adaptive immune responses are critical in the 
pathogenesis of ABC-HSR, providing abacavir-specific activation and maturation 
signals to antigen presenting cells, whilst the generation of abacavir-specific immune 
responses also appears to be contingent on ADH-mediated bioactivation. The 
exquisite HLA-B*5701+ restriction of abacavir modified ligands provides the most 
clinically relevant basis for genetic screening, although the involvement of toll-like 
receptors may also have therapeutic implications. 
 
